These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 12604666)

  • 21. Hesperidin induces antinociceptive effect in mice and its aglycone, hesperetin, binds to μ-opioid receptor and inhibits GIRK1/2 currents.
    Loscalzo LM; Yow TT; Wasowski C; Chebib M; Marder M
    Pharmacol Biochem Behav; 2011 Sep; 99(3):333-41. PubMed ID: 21624389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
    Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
    Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of extracellular sodium on mu-opioid receptors coupled to potassium channels coexpressed in Xenopus oocytes.
    Oz M; Spivak CE
    Pflugers Arch; 2003 Mar; 445(6):716-20. PubMed ID: 12632192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mu and delta opioid receptors are differentially desensitized by the coexpression of beta-adrenergic receptor kinase 2 and beta-arrestin 2 in xenopus oocytes.
    Kovoor A; Nappey V; Kieffer BL; Chavkin C
    J Biol Chem; 1997 Oct; 272(44):27605-11. PubMed ID: 9346897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional activation by central monoamines of human dopamine D(4) receptor polymorphic variants coupled to GIRK channels in Xenopus oocytes.
    Wedemeyer C; Goutman JD; Avale ME; Franchini LF; Rubinstein M; Calvo DJ
    Eur J Pharmacol; 2007 May; 562(3):165-73. PubMed ID: 17350612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of the endothelin receptor inhibits the G protein-coupled inwardly rectifying potassium channel by a phospholipase A2-mediated mechanism.
    Rogalski SL; Cyr C; Chavkin C
    J Neurochem; 1999 Apr; 72(4):1409-16. PubMed ID: 10098843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct activation by dopamine of recombinant human 5-HT1A receptors: comparison with human 5-HT2C and 5-HT3 receptors.
    Oz M; Zhang L; Rotondo A; Sun H; Morales M
    Synapse; 2003 Dec; 50(4):303-13. PubMed ID: 14556235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RGS14 prevents morphine from internalizing Mu-opioid receptors in periaqueductal gray neurons.
    Rodríguez-Muñoz M; de la Torre-Madrid E; Gaitán G; Sánchez-Blázquez P; Garzón J
    Cell Signal; 2007 Dec; 19(12):2558-71. PubMed ID: 17825524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two distinct forms of desensitization of G-protein coupled inwardly rectifying potassium currents evoked by alkaloid and peptide mu-opioid receptor agonists.
    Blanchet C; Sollini M; Lüscher C
    Mol Cell Neurosci; 2003 Oct; 24(2):517-23. PubMed ID: 14572471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Agonist induced homologous desensitization of mu-opioid receptors mediated by G protein-coupled receptor kinases is dependent on agonist efficacy.
    Kovoor A; Celver JP; Wu A; Chavkin C
    Mol Pharmacol; 1998 Oct; 54(4):704-11. PubMed ID: 9765514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct domains of the mu-opioid receptor control uncoupling and internalization.
    Celver J; Xu M; Jin W; Lowe J; Chavkin C
    Mol Pharmacol; 2004 Mar; 65(3):528-37. PubMed ID: 14978231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the relative efficacy and potency of mu-opioid agonists to activate Galpha(i/o) proteins containing a pertussis toxin-insensitive mutation.
    Clark MJ; Furman CA; Gilson TD; Traynor JR
    J Pharmacol Exp Ther; 2006 May; 317(2):858-64. PubMed ID: 16436499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Site of action of the general anesthetic propofol in muscarinic M1 receptor-mediated signal transduction.
    Murasaki O; Kaibara M; Nagase Y; Mitarai S; Doi Y; Sumikawa K; Taniyama K
    J Pharmacol Exp Ther; 2003 Dec; 307(3):995-1000. PubMed ID: 14534362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
    Zhao GM; Qian X; Schiller PW; Szeto HH
    J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opioid agonist and antagonist treatment differentially regulates immunoreactive mu-opioid receptors and dynamin-2 in vivo.
    Yoburn BC; Purohit V; Patel K; Zhang Q
    Eur J Pharmacol; 2004 Sep; 498(1-3):87-96. PubMed ID: 15363980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual effects of DAMGO [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin and CTAP (D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2) on adenylyl cyclase activity: implications for mu-opioid receptor Gs coupling.
    Szücs M; Boda K; Gintzler AR
    J Pharmacol Exp Ther; 2004 Jul; 310(1):256-62. PubMed ID: 14996951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opioid mu receptor activation inhibits sodium currents in prefrontal cortical neurons via a protein kinase A- and C-dependent mechanism.
    Witkowski G; Szulczyk P
    Brain Res; 2006 Jun; 1094(1):92-106. PubMed ID: 16733049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opioidergic modulation of excitability of rat trigeminal root ganglion neuron projections to the superficial layer of cervical dorsal horn.
    Takeda M; Tanimoto T; Ikeda M; Kadoi J; Nasu M; Matsumoto S
    Neuroscience; 2004; 125(4):995-1008. PubMed ID: 15120859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of TRPV1-expressing sensory neurons reduces spinal mu opioid receptors but paradoxically potentiates opioid analgesia.
    Chen SR; Pan HL
    J Neurophysiol; 2006 May; 95(5):3086-96. PubMed ID: 16467418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endogenous regulator of g protein signaling proteins reduce {mu}-opioid receptor desensitization and down-regulation and adenylyl cyclase tolerance in C6 cells.
    Clark MJ; Traynor JR
    J Pharmacol Exp Ther; 2005 Feb; 312(2):809-15. PubMed ID: 15383633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.